triumph-1 trial retatrutide 🚨 Phase 3 top-line results, much awaited and just announced ⬇️ 28.3% Weight loss at 80 weeks ⬇️ 30.3% weight loss at 104 weeks among adults with baseline BMI >35 A summary slide of the

Plus, its the easiest spot to get to if youre doing the injection yourself

We help protect Semaglutide (Ozempic, Rybelsus) and other temperature-sensitive injectables such as: Liraglutide (Victoza, Saxenda) Exenatide (Byetta, Bydureon) Albiglutide (Tanzeum) Dulaglutide (Trulicity) Lixisenatide (Adlyxin) Tirzepatide (Mounjaro, Zepbound) Explore our proven insulated packaging products below, trusted by pharmaceutical companies for safe and efficient GLP-1 drug shipping

The reported findings: Mean body weight reduction ranged from approximately 9% at the lowest dose to 20% at the highest dose, compared with 0.4% on placebo

N.FriasJ

Important safety information: Retatrutide is an investigational medication that hasnt been approved by the MHRA, FDA, or any other regulator as of May 2026